Coronavirus 2019 or COVID-19 is a novel entity which had led to many challenges among physicians due to its rapidly evolving nature. Vertigo or dizziness has recently been described as a clinical manifestation of COVID-19. Countless studies, emerging daily from various parts of the world, have revealed dizziness as one of the main clinical manifestation of COVID-19. This is not surprising as dizziness has historically been associated with viral infections.
An earlier published study from China found dizziness to be the most common neurological manifestation of COVID-19.1 Dizziness was proposed to occur ensuing the neuroinvasive potential of severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 virus which causes COVID-19. Baig et al postulated that the virus enters the neural tissue from circulation and binds to the angiotensin-converting enzyme 2 receptors found in the capillary endothelium.2 Apart from that, direct invasion, hypoxia, hypercoagulopathy, as well as immune-mediated insult were among the postulated mechanism of neuroinvasion leading to dizziness.3
A literature search was performed using articles published in PubMed on August 1, 2020, to identify dizziness as a clinical manifestation of COVID-19. The keywords used for the article search include giddiness, dizziness, vertigo, COVID-19, SARS CoV 2, Coronavirus disease. To our knowledge, this is the first article that outlines the association between dizziness and COVID-19.
We obtained 14 articles, which include 3 case reports and 11 studies (Table 1). A total of 141 patients were pooled from this review. All patients included in this review had dizziness/vertigo as a presenting symptom. Dizziness was the initial presentation of COVID-19 in 3/141 patients (2.13%),9,11,13 whereby in 2 of these patients, dizziness was later followed by respiratory symptoms.9,13 Most of the studies reporting on dizziness as a clinical manifestation hails from China (11/14), the epicenter which gave rise to the pandemic. Of the 14 studies included, dizziness was specifically investigated and treated only in 2 studies9,11 as dizziness was not the highlight in most studies, it was not investigated and described thoroughly. Additionally, the outcome of dizziness was mentioned only in 1 study by Malayala et al,11 whereby vestibular rehabilitation was carried out for the patient successfully.
Table 1.
Author | Country | Study design | Total patients with dizziness (%) | Investigation for dizziness | Treatment for dizziness | Outcome of dizziness |
---|---|---|---|---|---|---|
Chen et al4 | China | CS | 29 (20) | N/A | N/A | N/A |
Chen et al5 | China | CS | 21 (8) | N/A | N/A | N/A |
Han et al6 | China | CR | 1 | N/A | N/A | N/A |
Hu et al7 | China | CS | 1 (4.16) | N/A | N/A | N/A |
Karadas et al8 | Turkey | CS | 16 (16.7) | N/A | N/A | N/A |
Kong et al9 | China | CR | 1 | Electronystagmography, Pure tone, MRI brain | Betahistine, Danshenchuandomazine | N/A |
Lo et al10 | China | CS | 2 (20) | N/A | N/A | N/A |
Malayala et al11 | United States | CR | 1 (Vestibular neuritis) | Bedside neurological examination, CT brain | Meclizine, Benzodiazepine, Steroids, Vestibular rehabilitation | Resolve |
Mao et al1 | China | CS | 36 (16.8) | N/A | N/A | N/A |
Mi et al12 | China | CS | 3 (30) | N/A | N/A | N/A |
Sia et al13 | Canada | CR | 1 (Isolated) | N/A | N/A | N/A |
Vacchiano et al14 | Italy | CS | 11 (10) | N/A | N/A | N/A |
Wang et al15 | China | CS | 13 (9) | N/A | N/A | N/A |
Wang et al16 | China | CS | 5 (7) | N/A | N/A | N/A |
Abbreviations: CR, case report; CS, cross-sectional study; CT, computed tomography; MRI, magnetic resonance imaging; N/A, not available.
Dizziness, albeit a nonspecific COVID-19 symptom, requires thorough investigation notably to determine its leading cause including, acute labyrinthitis, vestibular neuritis, acute otitis media, or secondary to stroke following COVID-19.
We would like to emphasize that dizziness should not be taken lightly as it has been proven to be a notable clinical manifestation among COVID-19 patients. Parallel to that, association with other audiovestibular manifestations such as hearing loss and tinnitus ought to be determined. Persistent dizziness posttreatment from COVID-19 requires referral to the Otorhinolaryngology Department for thorough examination and investigation. Additionally, we recommend vestibular rehabilitation therapy, which has revealed promising results, to be carried out for stable COVID-19 patients with dizziness. Lastly, it is imperative that attending physicians remain vigilant, especially when managing nonspecific symptoms such as dizziness, as it can be easily overlooked.
Footnotes
ORCID iD: Jeyasakthy Saniasiaya https://orcid.org/0000-0003-1974-4379
References
- 1. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Baig A, Khaleeq A, Ali U, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction and proposed neurotropic mechanisms. ACS Neurosci. 2020;11(7):995–998. [DOI] [PubMed] [Google Scholar]
- 3. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;97;18–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Chen Q, Zheng Z, Zhang C, et al. Clinical characteristics of 145 patients with corona virus diseases 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection. 2020;48(4):543–551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Han W, Quan B, Guo Y, et al. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. J Med Virol. 2020;92(5):461–463. doi:10.1002/jmv.25711 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706–711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Karadas O, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID 19. Neurol Sci. 2020;41(8):1991–1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kong Z, Wang J, Li T, Zhang Z, Jian J. 2019 novel coronavirus pneumonia with onset of dizziness: a case report. Ann Transl Med. 2020;8(7):506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Lo IL, Lio CF, Cheong HH, et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int J Biol Sci. 2020;16(10):1698–1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Malayala SV, Raza A. A case of COVID-19-induced vestibular neuritis. Cureus. 2020;12(6):e8918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Mi B, Chen L, Xiong Y, Xue H, Xue H, Liu G. Characteristics and early prognosis of COVID-19 infection in fracture patients. J Bone Joint Surg Am. 2020;102(9):750–758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Sia J. Dizziness can be an early sole clinical manifestation for COVID-19 infection: a case report. JACEP Open. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Vacchiano V, Riguzzi P, Volpi L, et al. Early neurological manifestations of hospitalised COVID-19 patients. Neurol Sci. 2020:1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Wang D, Hu B, Hu Chang, et al. Clinical characteristics of 138 hospitalised patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769–777. [DOI] [PMC free article] [PubMed] [Google Scholar]